Chemomab Therapeutics Ltd. American Depositary Share — Graphique, cours et actualités (NASDAQ:CMMB) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Market Capitalization 14.38 M
Employee 12
Founded 2011
CEO N/A
Website www.chemomab.com
Headquarter Israel
FIGI BBG00N0PMGK1
Industry Biotechnologies

Chiffre d'affaires total

Résultat net

Bénéfice par action de base (BPA de base)

Dette totale

Flux de trésorerie disponible

Trésorerie et équivalents de trésorerie

Nouvelles

Le nebokitug de Chemomab montre un potentiel modificateur de la maladie dans l’essai sur la CSP

Chemomab’s nebokitug shows disease-modifying potential in PSC trial

Chemomab reports positive 48-week data for PSC drug nebokitug

ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition

Best Momentum Stocks to Buy for Oct. 23

New Strong Buy Stocks for Oct. 23: MQ, GES and More

SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study

Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis

NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs

Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan